The MIRD perspective 1999

Journal of Nuclear Medicine

Volumn 40, Issue 1, 1999, Pages

  Howell, Roger W ^a   Wessels, Barry W ^c   Loevinger, Robert ^c   Watson, Evelyn E ^b   Bolch, W E ^c   Brill, A B ^c   Charkes, N D ^c   Fisher, D R ^c   Hays, M T ^c   Robertson, J S ^c   Siegel, J A ^c   Thomas, S R ^c  

^a RUTGERS NEW JERSEY MEDICAL SCHOOL   (United States)

^b MIRD Committee   (United States)

^c NONE

Author keywords

[No Author keywords available]

Indexed keywords

RADIOISOTOPE;

DOSIMETRY; PRIORITY JOURNAL; RADIATION DOSE; RADIATION HAZARD; REVIEW;

EID: 0032942630     PISSN: 01615505     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (82)

1. Loevinger R, Budinger TF, Watson EE. MIRD primer for absorbed dose calculations, Revised. New York: The Society of Nuclear Medicine; 1991.
2. Snyder WS, Ford MR, Warner GG, Watson SB. "S," absorbed dose per unit cumulated activity far selected radionuclides and organs. MIRD Pamphlet No. 11. New York: Society of Nuclear Medicine; 1475.
3. Thomas SR, Stahin MG, Chen CT, Samaratunga RC. MIRD Pamphlet No. 14 Revised: a dynamic urinary bladder model for radiation dose calculations. J Nucl Med 1998:40. Upcoming April.
4. Bouchet LG, Bolch WE, Weber DA, Atkins HL, Poston JW Sr. MIRD Pamphlet No. 15: radionuclide S values in a revised model of the adult head and brain. J Nucl Med 1998;40. Upcoming March.
5. Siegel JA, Thomas SR, Stubhs JB, et al. MIRD Pamphlet No. 16: techniques for quantitative radiopharmaceutical biodistribution data acquisition and analysis for use in human radiation dose estimates. J. Nucl Med 1997;1998;40. Upcoming February.
6. Bolch WE, Bouehet LG, Robertson JS, et al. MIRD Pamphlet No. 17: the dosimetry of nonuniform activity distributions - radionuclide S values at the voxel level. J Nucl Med 1998;40. This issue.
7. Marinelli LD, Quimby EH, Hine GJ. Dosage determination with radioactive isotopes. II. Practical considerations in therapy and protection. Am J Roentg Radiat Ther 1948;59:260-280.
8. Marinelli LD, Quimby EH, Hine GJ. Dosage determination with radioactive isotopes I. Nucleonics 1948;2:56-66.
9. Marinelli LD, Quimby EH, Hine GJ. Dosage determination with radioactive isotopes II. Nucleonics 1948;2:44-49.
10. Wasserman LR, Loevinger R. Use of radioactive isotopes in medicine. Adv Intern Med 1951;4:77-161.
11. Loevinger R, Japha EM, Brownell GL. Discrete radioisotope sources. In: Hine GJ, Brownell GL, eds. Radiation dosimetry. New York: Academic Press; 1956:693-755.
12. Loevinger R, Holt JG, Hine GJ. Internally administered radioisotopes. In: Hine GJ, Brownell GL, eds. Radiation dosimetry. New York: Academic Press; 1956:801-873.
13. Loevinger R. Distributed radionuclide sources. In: Attix FH, Tochilin E, eds. Radiation dosimetry, 2nd ed. New York: Academic Press; 1969:51-90.
14. Mayneord WV. The mathematical theory of integral dose in radium therapy. Br J Radiol 1945;18:12-19.
15. Ellett WM, Callahan AB, Brownell GL. Gamma-ray dosimetry of internal emitters. I. Monte Carlo calculations of absorbed dose from point sources. Br J Radiol 1964;37: 45-52.
16. Ellett WH, Callahan AB, Brownell GL. Gamma-ray dosimetry of internal emitters. II. Monte Carlo calculations of absorbed dose from uniform sources. Br J Radiol 1965;38:541-544.
17. Loevinger R, Berman M. A schema for absorbed-dose calculations for biologically-distributed radionuclides. MIRD Pamphlet No. 1. J Nucl Med 1968;9(suppl 1):7-14.
18. Weber DA, Eckerman KF, Dillman LT, Ryman JC. MIRD: radionuclide data and decay schemes. New York: Society of Nuclear Medicine; 1989.
19. Goddu SM, Howell RW, Rao DV. A generalized approach to absorbed dose calculations for dynamic tumor and organ masses. J Nucl Med 1995;36:1923-1927.
20. Howell RW. The MIRD schema: from organ to cellular dimensions. J Nucl Med 1994;35:531-533.
21. Rescigno A, Thakur AK, Brill AB, Mariani G. Tracer kinetics: a proposal for unified symbols and nomenclature. Phys Med Biol 1990;35:449-465.
22. Berman M. Kinetic models far absorbed Jose calculations, MIRD Pamphlet No 12. New York: Society of Nuclear Medicine; 1976.
23. Snyder WS, Ford MR, Warner GG. Estimates of specific absorbed fractions for photon sources uniformly distributed in various organs of a heterogeneous phantom, MIRD Pamphlet No. 5, Revised. New York: Society of Nuclear Medicine; 1978.
24. Press OW, Eary JF, Appelbaum FR, et al. Radiolabeled antibody therapy of B-cell lymphoma with autologous bone marrow support. N Engl J Med 1993;329:1219-1224.
25. Sgouros G, Divgi CR, Scott AM, Williams J, Larson SM. Hematologic toxicity in radioimmunotherapy: an evaluation of different predictive measures. J Nucl Med 1996;37(suppl):43P-44P.
26. Cristy M. Applying the reciprocal dose principle to heterogeneous phantoms. Phys Med Biol 1983;28:1289-1303.
27. Jones JP, Wagner J, Brill AB. An in vivo evaluation of standard man model absorbed fractions using Tc-99m sulfur colloid. In: Cloutier RJ, Coffey JL, Snyder WS, eds. Radiopharmaceutical dosimetry symposium. Rockville, MD: HEW Publication (FDA) 76-8044; 1976:283-289.
28. Snyder WS, Ford MR, Warner GG, Fisher HL. MIRD Pamphlet No. 5. Estimates of specific absorbed fractions for monoenergetic photon sources uniformly distributed in various organs of a heterogeneous phantom. J Nucl Med 1969;10(suppl 3):5-52.
29. Weber DA, Makler PT, Watson EE, Coffey JL, Thomas SR, London J. MIRD dose estimate report no. 13: radiation absorbed dose from technetium-99m-labeled bone imaging agents. J Nucl Med 1989;30:1117-1122.
30. ICRU. Methods of assessment of absorbed dose in clinical use of radionuclides, Report 32. Bethesda, MD: International Commission on Radiation Units and Measurements; 1979.
31. 131I-CC49 radioimmunotherapy in three Phase II clinical trials. Cancer Biother Radiopharm 1997;12:79-87.
32. Poston JW Sr, Aissi A, Hui TE, Jimba BM. A preliminary model of the circulating blood for use in radiation dose calculation. In: Schlafke-Stelson AT, Watson EE, eds. Proceedings of fourth international radiopharmaceutical dosimetry symposium. CONF-851113 (DE86010102). Springfield, VA: National Technical Information Service; 1986:574-586.
33. Akabani G, Poston JW Sr, Absorbed dose calculations to blood and blood vessels for internally deposited radionuclides. J Nucl Med 1991;32:830-834.
34. Watson EE, Stabin MG, Davis JL, Eckerman KF. A model of the peritoneal cavity for use in internal dosimetry. J Nucl Med 1989;30:2002-2011.
35. Poston JW Jr, Kodimer KA, Bolch WE, Poston JW Sr. A revised model for the calculation of absorbed energy in the gastrointestinal tract. Health Phys 1996;71:307-314.
36. Poston JW Jr, Kodimer KA, Bolch WE, Poston JW Sr. Calculation of absorbed energy in the gastrointestinal tract. Health Phys 1996;71:300-306.
37. Coffey JL, Cristy M, Warner GG. Specific absorbed fractions for photon sources uniformly distributed in the heart chambers and heart wall of a heterogeneous phantom, MIRD Pamphlet No. 13. J Nucl Med 1981;22:65-71.
38. Cristy M, Eckerman KF. Specific absorbed fraction of energy at various ages from internal photon source. Vols. I-VII: Methods; specific absorbed fractions for 1-, 5-, 10-, 15-year old; newborn; adult male, ORNL/TM-8381. Oak Ridge, TN: Oak RidgeNational Laboratory; 1987.
39. Nuclear neurology issue. J Nucl Med 1996;37:1069-1274.
40. Saha GB, Macintyre WJ, Go RT. Radiopharmaceuticals for brain imaging. Semin Nucl Med 1994;24:324-349.
41. Kwok CS, Prestwich WV, Wilson BC. Calculation of radiation doses for nonuniformly distributed beta and gamma radionuclides in soft tissue. Med Phys 1985;12:405-412.
42. Humm JL, Dosimetric aspects of radiolabeled antibodies for tumor therapy. J Nucl Med 1986;27:1490-1497.
43. Erdi AK, Wessels BW, DeJager R. Tumor activity confirmation and isodose curve display for patients receiving iodine-131-labeled 16.88 human monoclonal antibody. Cancer 1994;73:932-944.
44. Sgouros G, Chiu S, Pentlow KS, et al. Three-dimensional dosimetry for radiotherapy treatment planning. J Nucl Med 1993;34:1595-1601.
45. Howell RW, Rao DV, Haydock C. Dosimetry techniques for therapeutic applications of incorporated radionuclides. In: Adelslein SJ, Kassis AI, Burt RW, eds. Dosimetry of administered radionuclides. Washington, DC: American College of Nuclear Physicians; 1990:215-256.
46. Makrigiorgos GM, Adelstein SJ, Kassis AI. Limitations of conventional internal dosimctry at the cellular level. J Nucl Med 1989;30:1856-1864.
47. Griffith MH, Yorke ED, Wessels BW, DeNardo GL, Neacy WP. Direct dose confirmation of quantitative autoradiography with micro-TLD measurements for radioimmunotherapy. J Nucl Med 1988;29:1795-1809.
48. Sastry KSR, Rao DV, Dosimetry of low energy electrons. In: Rao DV, Chandra R, Graham M, eds. Physics of nuclear medicine: recent advances. New York: American Institute of Physics; 1984:169-208.
49. 125IUdR in mammalian cells: Implications of localized energy deposition by Auger processes. Radiat Res 1987;109:78-89.
50. Adelstein SJ, Kassis AI, Sastry KSR. Cellular vs. organ approaches to dose estimates. In: Schlafke-Stelson AT, Watson EE, eds. Proceedings of fourth international radiopharmaceutical dosimetry symposium. Springfield, VA: National Technical Information Service; 1986:13-25.
51. Kassis AI. The MIRD approach: remembering the limitations. J Nucl Med 1992;33: 781-782.
52. Sgouros G, Barest G, Thekkumthala J, et al. Treatment planning for internal radionuclide therapy: three-dimensional dosimetry for nonuniformly distributed radionuclides. J Nucl Med 1990;31:1884-1891.
53. Roberson PL. Quantitative autoradiography tor the study of radiopharmaceutical uptake and dose heterogeneity. J Nucl Med 1992;33:1833-1835.
54. Roberson PL, Buchsbaum DJ, Heidom DB, Ten Haken RK. Three-dimensional tumor dosimetry for radioimmunotherapy using serial autoradiography. Int J Radiat Oncol Biol Phys 1992;24:329-334.
55. Yorke ED, Williams LE, Demidecki AJ, Heidorn DB, Roberson PL, Wessels BW. Multicellular dosimetry for beta-emitting radionuclides: autoradiography, thermoluminescent dosimetry and three-dimensional dose calculations. Med Phys 1993;20:543-550.
56. Humm JL, Macklis RM, Bump K, Cobb LM, Chin LM. Internal dosimetry using data derived from autoradiographs. J Nucl Med 1993;34:1811-1817.
57. Goddu SM, Howell RW, Bouchet LG, Bolch WE, Rao DV. MIRD cellular S values: self-absorbed dose per unit cumulated activity for selected radionuclides and monoenergetic electron and alpha particle emitters incorporated into different cell compartments. Reston, VA: Society of Nuclear Medicine; 1997.
58. Fowler JF. Radiobiological aspects of low dose rates in radioimmunotherapy. Int J Radiat Oncol Biol Phys 1990;18:1261-1269.
59. Howell RW, Goddu SM, Rao DV. Proliferation and the advantage of longer-lived radionuclides in radioimmunotherapy. Med Phys 1998;25:37-42.
60. Wilder RB, DeNardo GL, Sheri S, Fowler JF, Wessels BW, DeNardo SJ. Application of the linear-quadratic model to myelotoxieity associated with radioimmunotherapy. Eur J Nucl Med 1996;23:953-957.
61. National Research Council. Health effects of radon and other internally deposited alpha-emitters, BE1R IV. Washington, DC: National Academy Press, 1988.
62. Howell RW, Goddu SM, Narra VR, Fisher DR, Schemer RE, Rao DV. Radiotoxicity of gadolinium-148 and radium-223 in mouse testes: relative iological effectiveness of alpha panicle emitters in vivo. Radiat Res 1997;147:342-348.
63. Rao DV, Narra VR, Howell RW, Govelitz GF, Sastry KSR. In-vivo radiotoxicity of DNA-incorporated 1-125 compared with that of densely ionising alpha-particles. Lancet 1989;ii:650-653.
64. Humm JL, Howell RW, Rao DV. Dosimetry of Auger electron emitting radionuclides: Report No. 3 of the AAPM Nuclear Medicine Task Group No. 6. Med Phys 1994;21:1901-1915.
65. NCRP. The relative biological effectiveness of radiations of different quality, Report No. 104. National Council on Radiation Protection and Measurements, Bethesda, MD; 1990.
66. NCRP. Influence of dose and its distribution in time on dose-response relationships for Low-LET radiations, Report No. 64. National Council on Radiation Protection and Measurements, Bethesda, MD; 1980.
67. Knox SJ, Goris ML, Wessels BW. Overview of animal studies comparing radioimmunotherapy with dose equivalent external beam irradiation. Radiother Oncol 1992; 23:111-117.
68. Langmuir VK, Fowler JF, Knox SJ, Wessels BW, Sutherland RM, Wong JYC. Radiobiology of radiolabelcd antibody therapy as applied to tumor dosimetry. Med Phys 1993;20:601-610.
69. Wessels BW. Current status of animal radioimmunotherapy. Cancer Res 1990; 50(suppl):970s-973s.
70. Narra VR, Howell RW, Harapanhalli RS, Sastry KSR, Rao DV. Radiotoxicity of some 1-123, 1-125, and 1-131 labeled compounds in mouse testes: implications for radiopharmaceutical design. J Nucl Med 1992;33:2196-2201.
71. Scott KS, Hainan KE. Measurement of dose to thyroid carcinoma metastases from radio-iodine therapy. Br J Radiol 1970;43:256-262.
72. Becker DV, Hurley JR. Complications of radioiodine treatment of hyperthyroidism. Semin Nucl Med 1971;1:442-460.
73. Silberstein EB. Dosage and response in radiopharmaceutical therapy of painful osseus metastases. J Nucl Med 1996;37:249-252.
74. Halnan KE, Russell MH. Polycythemia vera. Lancet 1965;ii:760-763.
75. 32P in treatmenl of polycythemia vera. Blood 1968;32:492-499.
76. Modan B. Inter-relationship between polycythemia vera, leukemia and myeloid metaplasia. Clin Haematol 1975;4:427-439.
77. Wilder RB, DeNardo GL, DeNardo SJ. Radioimmunotherapy. Recent results and future directions. J Clin Oncol 1996;14:1383-1400.
78. Maxon HR, Thomas SR, Hertzberg VS, et al. Relation between effective radiation dose and outcome of radioiodine therapy for thyroid cancer. N Engl J Med 1983;309:937-941.
79. Kaminski MS, Zasadny KR, Francis IR, et al. Iodine-131 -anti-B1 radioimmunotherapy for B-cell lymphoma. J Clin Oncol 1996;14:1974-1981.
80. Kolbert KS, Sgouros G, Scott AM, et al. Implementation and evaluation of patient-specific three-dimensional internal dosimetry. J Nucl Med 1997;38:301-308.
81. Akabani G, Hawkins WG, Eckblade MB, Leichner PK. Patient-specific dosimetry using quantitative SPECT imaging and three-dimensional discrete Fourier transform convolution. J Nucl Med 1997;38:308-314.
82. Loevinger R. The MIRD perspective. In: Adelstein SJ, Kassis AI, Bun RW, eds. Dosimetry of administered radionuclides, Addendum, Washington, DC: American College of Nuclear Physicians: 1990:1-16.